Department of Psychiatry, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore - 560 029, India.
Indian J Psychiatry. 2007 Oct;49(4):256-61. doi: 10.4103/0019-5545.37665.
The correlation between cannabis and negative mental health outcomes has been unequivocally established. Nevertheless, there is still a great need to research different dimensions of cannabis-related disorders, among which the study of cannabis-related psychosis is very important. There is a dearth of research regarding phenomenology and effect of abstinence, particularly from India. This study attempts to research the clinical presentation of cannabis-related psychosis and effect of abstinence.
The aim of the present study was to document the clinical presentation of cannabis-related psychosis at presentation and after 7 days' abstinence from cannabis.
Subjects with psychosis following cannabis use without any other prior or concurrent psychiatric disorder presenting to the outpatient department of a large tertiary care hospital were consecutively recruited for study. They were observed in a drug-free, protected environment for 7 days, during which clinical features were recorded using the Brief Psychiatric Rating Scale (BPRS).
Twenty male subjects were recruited and phenomenology was evaluated on the BPRS. Items with highest frequencies were unusual thought content (100%), excitement (75%), grandiosity (75%), hallucinatory behavior (70%) and uncooperativeness (65%). The least common symptoms were anxiety (5%), guilt feeling (5%), depressive mood (10%), motor retardation (10%) and blunted affect (30%). Nine subjects (45%) presented with cognitive dysfunction. Affective psychosis was the predominant diagnosis. At the end of 1 week of abstinence from cannabis, there was a significant decrease in scores. Significant improvement was observed in cognitive dysfunction, conceptual disorganization, grandiosity, tension, hostility, hallucinatory behavior and excitement.
Cannabis-related psychosis presented with a predominantly affective psychosis and prominent thought disorder, excitement and violence. All subjects showed improvement in symptoms with abstinence from cannabis. A small heterogeneous sample and short duration of observation were the important limitations of this study.
大麻与负面心理健康结果之间的相关性已得到明确证实。然而,仍然需要研究大麻相关障碍的不同方面,其中研究大麻相关精神病非常重要。关于大麻相关精神病的现象学和戒断效果,特别是来自印度的研究还很缺乏。本研究试图研究大麻相关精神病的临床表现和戒断效果。
本研究旨在记录大麻使用后出现精神病的临床表现,并在大麻戒断 7 天后记录这些表现。
连续招募在大型三级保健医院的门诊部就诊的、无其他先前或同时存在的精神障碍的、因使用大麻而出现精神病的患者作为研究对象。在无毒品、受保护的环境中对他们进行为期 7 天的观察,在此期间使用简明精神病评定量表(BPRS)记录临床特征。
共招募了 20 名男性受试者,并用 BPRS 评估了他们的表现。出现频率最高的项目包括异常思维内容(100%)、兴奋(75%)、夸大观念(75%)、幻觉行为(70%)和不合作(65%)。最不常见的症状是焦虑(5%)、内疚感(5%)、抑郁情绪(10%)、运动迟缓(10%)和情感迟钝(30%)。9 名受试者(45%)出现认知功能障碍。以情感性精神病为主要诊断。在大麻戒断 1 周结束时,评分显著下降。认知功能障碍、概念紊乱、夸大观念、紧张、敌意、幻觉行为和兴奋均有显著改善。
大麻相关精神病以情感性精神病和明显的思维障碍、兴奋和暴力为主要表现。所有患者在戒断大麻后症状均有改善。本研究的重要局限性是样本小且观察时间短。